Differentiation of pancreatic endocrine cells
US12385013B2 · kind B2 · utility
0Cited by
18References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 4, 2024 |
| Grant date | Aug 12, 2025 |
| Priority date | — |
| Expiry date | Sep 4, 2044 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2501/415
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are compositions and methods related to differentiation of stem cells into pancreatic endocrine cells. In some aspects, the methods provided herein relate to generation of pancreatic β cell, α cell, δ cells, and EC cells in vitro. In some aspects, the disclosure provides pharmaceutical compositions including the cells generated according to the methods disclosed herein, as well as methods of treatment making use thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.